Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.4799
Delayed Data
As of Jul 31
 -0.0001 / -0.02%
Today’s Change
0.43
Today|||52-Week Range
1.04
-34.26%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.48
Today’s open0.48
Day’s range0.47 - 0.49
Volume67,528
Average volume (3 months)409,926
Market cap$42.4M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...+0.00+0.01%
OPGNOpGen Inc-0.06-1.77%
--Protea Biosciences G...0.000.00%
BCLIBrainstorm Cell Ther...+0.05+1.58%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts